New cancer clinical trial: A Phase I Study of BTRC4017A in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

Published on: February 27, 2018 at 12:00PM
Condition:   Solid Tumors
Intervention:   Drug: BTRC4017A
Sponsor:   Genentech, Inc.
Recruiting
http://ift.tt/2oBMrct